Overview

Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.
Phase:
Phase 4
Details
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Medical University of South Carolina
Collaborators:
Brigham and Women's Hospital
Medical University of South Carolina
Northwestern University
Patient-Centered Outcomes Research Institute
University of Maryland
University of Maryland, Baltimore
University of Massachusetts, Worcester
Treatments:
Aspirin
Rivaroxaban
Warfarin